News & events

Webinars

April 26, 2017 1pm EST

Going Beyond RECIST – How Volumetric and Functional Analysis Can Add Value to Your Oncology Clinical Trials

Hosted by: Median Technologies Presented by:  Dr. Robert Ford, Clinical Trials Imaging Consulting, LLC April 26, 2017 at 1pm EST Three-dimensional, volume-based measurements…

Hosted by: Median Technologies

Presented by:  Dr. Robert Ford, Clinical Trials Imaging Consulting, LLC

April 26, 2017 at 1pm EST

Three-dimensional, volume-based measurements address some of the inherent limitations of unidimensional RECIST measurements, provide additional measures of efficacy for modern drug classes, and allow for earlier detection of therapeutic response. Early studies indicate that volume-based measurements are both medically meaningful and add value to a clinical trial. Volume measurements can be easily incorporated into existing clinical trial workflows using segmentation software, that also improves trial efficiency and reproducibility.

What you will learn in this webinar:

The Difference between Routine Versus Advanced Endpoints

More about Volume-Based Endpoints and When to Use Them;

Making Volumetric Tumor Measurements:The Nuts and Bolts

Adding Value to Clinical Trials: Are Volumetric Assessments a True Reflection of Drug Response?

Register today!

Register Here
See all webinars

Press releases

6 April 2017, SOPHIA ANTIPOLIS, France and BOSTON, USA

Median Technologies and inVentiv Health Announce Strategic Alliance to Provide Best-in-Class Medical Image Analysis and Management Services for Clinical Trials

Median Technologies, the Imaging Phenomics Company™, and inVentiv Health, a leading biopharmaceutical professional services company, today announced a strategic alliance to offer biopharmaceutical clients with best-in-class medical image analysis and management services for early to late stage oncology clinical trials. The alliance will provide inVentiv clients with the most advanced imaging biomarkers, at a time when 73 percent of cancer compounds in clinical trials involve biomarkers in their research and development design.

Read more
See all press releases

Conferences

June 19 - 22, San Diego, CA

Bio International Convention 2017

Median will be presenting at and participating in the Bio International Convention 2017 on June 19 – 22. Please join us in the…

Median will be presenting at and participating in the Bio International Convention 2017 on June 19 – 22. Please join us in the France Pavilion # 3217 and at our interactive panel discussion on ”The Oncology Phase 1 Trial of the Future: Delivering Promising Drugs More Efficiently and Rapidly”.

Visit conference website

Visit conference website
See all conferences

In the press

See all in the press

Blog

See all blog entries

Cookies help us deliver our services. By using our services, you agree to our use of cookies.